Jessica Matta

Jessica Matta

Company: Odimma therapeutics

Job title: Co-Founder & Chief Executive Officer & Chief Scientific Officer


Optimising DNA-Based Cancer Vaccines for Improved Immunogenicity 4:30 pm

• Developing neoantigen cancer vaccines based on DNA done at a very small scale • Addressing the reduced manufacturing time as the production process (there are a lot of benefits in quickly producing a vaccine per patient) • Utilising the benefits of adjuvants with DNA to induce strong cancer-specific immune responses • Currently in preclinical…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.